ΟΣΤΕΟΠΌΡΩΣΗ ΤΡΟΦΕΣ
Παραπομπές
1. Coughlan T, Dockery F. Osteoporosis and fracture risk in older people. Clinical Medicine (London, England). 2014 Apr;14(2):187-191. DOI: 10.7861/clinmedicine.14-2-187. PMID: 24715132; PMCID: PMC4953292.
https://europepmc.org/article/MED/24715132
2. Wu D, Cline-Smith A, Shashkova E, Perla A, Katyal A, Aurora R. T-Cell Mediated Inflammation in Postmenopausal Osteoporosis. Front Immunol. 2021 Jun 30;12:687551. doi: 10.3389/fimmu.2021.687551. PMID: 34276675; PMCID: PMC8278518.
https://pubmed.ncbi.nlm.nih.gov/34276675/
3. Srivastava M, Deal C. Osteoporosis in elderly: prevention and treatment. Clin Geriatr Med. 2002 Aug;18(3):529-55. doi: 10.1016/s0749-0690(02)00022-8. PMID: 12424871.
https://pubmed.ncbi.nlm.nih.gov/12424871
4. Yong EL, Logan S. Menopausal osteoporosis: screening, prevention and treatment. Singapore Medical Journal. 2021 Apr;62(4):159-166. DOI: 10.11622/smedj.2021036. PMID: 33948669; PMCID: PMC8801823.
https://europepmc.org/article/MED/33948669
5. Brown JP. Long-Term Treatment of Postmenopausal Osteoporosis. Endocrinol Metab (Seoul). 2021 Jun;36(3):544-552. doi: 10.3803/EnM.2021.301. Epub 2021 Jun 22. PMID: 34154042; PMCID: PMC8258325.
https://pubmed.ncbi.nlm.nih.gov/34154042/
6. Are you at risk for Osteoporosis? Washington University Orthopedics
https://www.ortho.wustl.edu/content/Education/3662/Patient-Education/Educational-Materials/Are-you-at-risk-for-Osteoporosis.aspx
7. Endocrine Society."Menopause and Bone Loss | Endocrine Society." Endocrine.org, Endocrine Society, 11 January 2023,
https://www.endocrine.org/patient-engagement/endocrine-library/menopause-and-bone-loss
8. - - -
9. - - -
10. Tsagari A, Papakitsou E, Dionyssiotis Y, Rizou S, Galanos A, Lyritis GP. Evaluation of commonly used nutritional assessment methods in hip fracture patients. J Frailty Sarcopenia Falls. 2017 Sep 1;2(3):39-44. PMID: 32313849; PMCID: PMC7161933.
https://pubmed.ncbi.nlm.nih.gov/32313849/
1. Coughlan T, Dockery F. Osteoporosis and fracture risk in older people. Clinical Medicine (London, England). 2014 Apr;14(2):187-191. DOI: 10.7861/clinmedicine.14-2-187. PMID: 24715132; PMCID: PMC4953292.
https://europepmc.org/article/MED/24715132
2. Wu D, Cline-Smith A, Shashkova E, Perla A, Katyal A, Aurora R. T-Cell Mediated Inflammation in Postmenopausal Osteoporosis. Front Immunol. 2021 Jun 30;12:687551. doi: 10.3389/fimmu.2021.687551. PMID: 34276675; PMCID: PMC8278518.
https://pubmed.ncbi.nlm.nih.gov/34276675/
3. Srivastava M, Deal C. Osteoporosis in elderly: prevention and treatment. Clin Geriatr Med. 2002 Aug;18(3):529-55. doi: 10.1016/s0749-0690(02)00022-8. PMID: 12424871.
https://pubmed.ncbi.nlm.nih.gov/12424871
4. Yong EL, Logan S. Menopausal osteoporosis: screening, prevention and treatment. Singapore Medical Journal. 2021 Apr;62(4):159-166. DOI: 10.11622/smedj.2021036. PMID: 33948669; PMCID: PMC8801823.
https://europepmc.org/article/MED/33948669
5. Brown JP. Long-Term Treatment of Postmenopausal Osteoporosis. Endocrinol Metab (Seoul). 2021 Jun;36(3):544-552. doi: 10.3803/EnM.2021.301. Epub 2021 Jun 22. PMID: 34154042; PMCID: PMC8258325.
https://pubmed.ncbi.nlm.nih.gov/34154042/
6. Are you at risk for Osteoporosis? Washington University Orthopedics
https://www.ortho.wustl.edu/content/Education/3662/Patient-Education/Educational-Materials/Are-you-at-risk-for-Osteoporosis.aspx
7. Endocrine Society."Menopause and Bone Loss | Endocrine Society." Endocrine.org, Endocrine Society, 11 January 2023,
https://www.endocrine.org/patient-engagement/endocrine-library/menopause-and-bone-loss
8. - - -
9. - - -
10. Tsagari A, Papakitsou E, Dionyssiotis Y, Rizou S, Galanos A, Lyritis GP. Evaluation of commonly used nutritional assessment methods in hip fracture patients. J Frailty Sarcopenia Falls. 2017 Sep 1;2(3):39-44. PMID: 32313849; PMCID: PMC7161933.
https://pubmed.ncbi.nlm.nih.gov/32313849/
